1. PSVII-32 Profiling peripheral microRNA in normal- versus over-conditioned dairy cows during dry-off and early lactation. (7th December 2018) Authors: Urh, C; Schuh, K; Zamarian, V; Webb, L; Lecchi, C; Alaedin, M; Sadri, H; Ghaffari, M; Dusel, G; Koch, C; Trakooljul, N; Wimmers, K; Ceciliani, F; Sauerwein, H Journal: Journal of animal science Issue: Volume 96(2018)Supplement 3 Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Specific IgG subclass antibody pattern toAspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Issue 1 (1st January 1999) Authors: Skov, M; Pressler, T; Jensen, H E; Høiby, N; Koch, C Journal: Thorax Issue: Volume 54:Issue 1(1999) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Issue 11 (November 1990) Authors: Høiby, N; Koch, C Journal: Thorax Issue: Volume 45:Issue 11(1990) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Novel primary thymic defect with T lymphocytes expressing gamma delta T cell receptor. Issue 7 (July 1989) Authors: Geisler, C; Pallesen, G; Platz, P; Odum, N; Dickmeiss, E; Ryder, L P; Svejgaard, A; Plesner, T; Larsen, J K; Koch, C Journal: Journal of clinical pathology Issue: Volume 42:Issue 7(1989) Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Diminished concentrations of insulin-like growth factor I in cystic fibrosis. Issue 6 (June 1995) Authors: Laursen, E M; Juul, A; Lanng, S; Høiby, N; Koch, C; Müller, J; Skakkebaek, N E Journal: Archives of disease in childhood Issue: Volume 72:Issue 6(1995) Page Start: 494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Glucose tolerance in cystic fibrosis. Issue 5 (May 1991) Authors: Lanng, S; Thorsteinsson, B; Erichsen, G; Nerup, J; Koch, C Journal: Archives of disease in childhood Issue: Volume 66:Issue 5(1991) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bone mineral status in 134 patients with cystic fibrosis. Issue 3 (1st September 1999) Authors: Laursen, E M; Mølgaard, C; Michaelsen, K F; Koch, C; Müller, J Journal: Archives of disease in childhood Issue: Volume 81:Issue 3(1999) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cystic fibrosis. 7. Management of cystic fibrosis in different countries. Cystic fibrosis in Copenhagen. Issue 5 (May 1991) Authors: Koch, C; Høiby, N Journal: Thorax Issue: Volume 46:Issue 5(1991) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Issue 1 (January 1992) Authors: Pedersen, S S; Høiby, N; Espersen, F; Koch, C Journal: Thorax Issue: Volume 47:Issue 1(1992) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P11.38 The Galectin-1 inhibitor OTX-008 has antiproliferative effects on human glioblastoma cells independent of MGMT-promotor status. (6th September 2019) Authors: Goett, H; Kolodziej, M; Pons-Kühnemann, J; Schwarm, F; Koch, C; Uhl, E; Stein, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗